DK0764209T3 - Albuminekspression i gær - Google Patents

Albuminekspression i gær

Info

Publication number
DK0764209T3
DK0764209T3 DK95921063T DK95921063T DK0764209T3 DK 0764209 T3 DK0764209 T3 DK 0764209T3 DK 95921063 T DK95921063 T DK 95921063T DK 95921063 T DK95921063 T DK 95921063T DK 0764209 T3 DK0764209 T3 DK 0764209T3
Authority
DK
Denmark
Prior art keywords
pct
yeast
sec
albumin expression
date
Prior art date
Application number
DK95921063T
Other languages
Danish (da)
English (en)
Inventor
Patricia Carol Wood
Alan Victor Quirk
Original Assignee
Delta Biotechnology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delta Biotechnology Ltd filed Critical Delta Biotechnology Ltd
Application granted granted Critical
Publication of DK0764209T3 publication Critical patent/DK0764209T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95921063T 1994-06-07 1995-06-07 Albuminekspression i gær DK0764209T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9411356A GB9411356D0 (en) 1994-06-07 1994-06-07 Yeast strains
PCT/GB1995/001317 WO1995033833A1 (fr) 1994-06-07 1995-06-07 Souches de levure

Publications (1)

Publication Number Publication Date
DK0764209T3 true DK0764209T3 (da) 2001-03-19

Family

ID=10756304

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95921063T DK0764209T3 (da) 1994-06-07 1995-06-07 Albuminekspression i gær

Country Status (14)

Country Link
US (1) US5783423A (fr)
EP (1) EP0764209B1 (fr)
JP (1) JP3667339B2 (fr)
KR (1) KR100380532B1 (fr)
AT (1) ATE198624T1 (fr)
AU (1) AU698319B2 (fr)
CA (1) CA2190373C (fr)
DE (1) DE69519856T2 (fr)
DK (1) DK0764209T3 (fr)
ES (1) ES2156602T3 (fr)
GB (2) GB9411356D0 (fr)
GR (1) GR3035568T3 (fr)
PT (1) PT764209E (fr)
WO (1) WO1995033833A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6274305B1 (en) 1996-12-19 2001-08-14 Tufts University Inhibiting proliferation of cancer cells
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
US6258559B1 (en) * 1999-03-22 2001-07-10 Zymogenetics, Inc. Method for producing proteins in transformed Pichia
EP1183385B1 (fr) 1999-05-21 2006-07-19 Cargill Dow LLC Methodes et matieres destinees a la synthese de produits organiques
US6926898B2 (en) 2000-04-12 2005-08-09 Human Genome Sciences, Inc. Albumin fusion proteins
EP1363992A1 (fr) * 2001-02-26 2003-11-26 DSM IP Assets B.V. Procede permettant d'accroitre la concentration intracellulaire de glutamate dans la levure
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
EP1391510B1 (fr) 2001-05-29 2007-09-12 Asahi Glass Company Ltd. Procede de construction d'un hote et procede de production d'une proteine etrangere
US7176278B2 (en) 2001-08-30 2007-02-13 Biorexis Technology, Inc. Modified transferrin fusion proteins
CA2841097A1 (fr) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumine et proteines hybrides g-csf
WO2003059934A2 (fr) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Proteines de fusion d'albumine
WO2005003296A2 (fr) 2003-01-22 2005-01-13 Human Genome Sciences, Inc. Proteines hybrides d'albumine
US20060122374A1 (en) 2002-02-07 2006-06-08 Peter Mertins Albumin-fused anti-angiogenesis peptides
GB0217033D0 (en) 2002-07-23 2002-08-28 Delta Biotechnology Ltd Gene and polypeptide sequences
GB0224082D0 (en) * 2002-10-16 2002-11-27 Celltech R&D Ltd Biological products
US9057061B2 (en) 2003-12-23 2015-06-16 Novozymes Biopharma Dk A/S Gene expression technique
GB0329681D0 (en) * 2003-12-23 2004-01-28 Delta Biotechnology Ltd Gene expression technique
GB0329722D0 (en) 2003-12-23 2004-01-28 Delta Biotechnology Ltd Modified plasmid and use thereof
EP2330200B1 (fr) 2004-12-23 2017-04-05 Albumedix A/S Technique d'expression génique
DK2046826T3 (da) 2006-07-24 2011-10-24 Biorexis Pharmaceutical Corp Exendin-fusionsproteiner
WO2008019368A2 (fr) * 2006-08-07 2008-02-14 Teva Biopharmaceuticals Usa, Inc. Protéines de fusion d'albumine et d'insuline
EP2594583A1 (fr) 2007-08-08 2013-05-22 Novozymes Biopharma DK A/S Variants de transferrine et conjugues
US20110294988A1 (en) 2009-02-06 2011-12-01 Novozymes Bio Pharma DK A/S Purification Process
SG172789A1 (en) 2009-02-11 2011-08-29 Novozymes Biopharma Dk As Albumin variants and conjugates
WO2014138371A1 (fr) 2013-03-06 2014-09-12 Glaxosmithkline Llc Cellules hôtes et procédés d'utilisation
CA2919327C (fr) 2013-08-09 2022-06-21 Novozymes A/S Reduction de la teneur en acides hexenuroniques contenus dans de la pate de cellulose
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (fr) 2020-12-28 2022-07-07 Davol Inc. Matériaux hémostatiques pulvérulents secs réactifs comprenant une protéine et un agent de réticulation à base de polyéthylène glycol modifié multifonctionnalisé

Also Published As

Publication number Publication date
JPH10501123A (ja) 1998-02-03
US5783423A (en) 1998-07-21
GB2302329B (en) 1998-04-29
WO1995033833A1 (fr) 1995-12-14
DE69519856T2 (de) 2001-07-19
KR100380532B1 (ko) 2004-03-24
EP0764209A1 (fr) 1997-03-26
PT764209E (pt) 2001-05-31
ATE198624T1 (de) 2001-01-15
DE69519856D1 (de) 2001-02-15
CA2190373C (fr) 2003-01-07
GB9411356D0 (en) 1994-07-27
CA2190373A1 (fr) 1995-12-14
JP3667339B2 (ja) 2005-07-06
ES2156602T3 (es) 2001-07-01
GB2302329A (en) 1997-01-15
AU698319B2 (en) 1998-10-29
GR3035568T3 (en) 2001-06-29
AU2626295A (en) 1996-01-04
EP0764209B1 (fr) 2001-01-10
GB9622229D0 (en) 1996-12-18

Similar Documents

Publication Publication Date Title
ATE198624T1 (de) Expression von albumin in hefe
PL312712A1 (en) High level expression, purification and repeated creasing of group b(porynowe?) proteins of outer membrane of neisseria meningitidis
DE59507920D1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
NO965378D0 (no) Pyrazolo- og pyrolopyridiner
PT749478E (pt) Estirpes de levedura e albuminas modificadas
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE234111T1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
DE69534180D1 (de) Promotor der tie rezeptor protein kinase
MX9700244A (es) Utilizacion de un poliholosido en una composicion limpiadora o desmaquillante, y composicion que lo incluye.
ATE234614T1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
SE9400524D0 (sv) Energipreparat
NO961423D0 (no) Oligopeptider avledet fra C-reaktive proteinfragmenter
AU637589B2 (en) Ancrod proteins, their production and use
GR930300003T1 (en) Inhibitor of proliferation of endothelial cells.
IL99940A0 (en) Beta-galactoside binding proteins,methods for the production thereof,and pharmaceutical compositions containing the same
DE69323191D1 (de) Wasserlösliche retinoide
DE59611353D1 (de) Transketolase-verwandtes protein
AU7614798A (en) High level expression, purification and refolding of the Neisseria meningitidis outer membrane group B porin proteins
ATE315583T1 (de) Analoge des thymosin alpha 1
ATE235260T1 (de) Verfahren zum herstellen von nebenwirkungsfreien konstrastmitteln bei ultrafiltration